Product Title: BPC-157 TB-500 Blend X 10mg
URL handle: bpc-157-tb-500-blend-10mg-biolongevity-labs
SKU: BPTB55
Brand: Biolongevity Labs
Current URL: https://fmihealth.com/products/bpc-157-tb-500-blend-10mg-biolongevity-labs
Meta Title: BPC-157 TB-500 Blend X 10mg
Meta Description: Description-- BPC‑157 + TB‑500 Blend (10 mg): This blend contains 5 mg of BPC‑157 and 5 mg of TB‑500 per vial, combining two peptides with overlapping regenerative properties. Their complementary mechanisms suggest potential synergistic effects in tissue repair, angiogenesis, and inflammation modulation. Both peptides
Health Conditions: Healing | Collagen Synthesis | Angiogenesis

Description HTML:
<p>Description-- <!--StartFragment --><strong>BPC‑157 + TB‑500 Blend (10 mg): </strong>This blend contains 5 mg of BPC‑157 and 5 mg of TB‑500 per vial, combining two peptides with overlapping regenerative properties. Their complementary mechanisms suggest potential synergistic effects in tissue repair, angiogenesis, and inflammation modulation. Both peptides are provided in lyophilized form (freeze‑dried, filler‑free) to preserve purity and stability.</p> <p> </p> <p><strong>Mechanistic Claims</strong></p> <ul> <li><strong>BPC‑157 (Body Protection Compound‑157):</strong></li> <ul> <li>Derived from a protective protein in gastric juice; stable in acidic environments.</li> <li>Acts via<strong> </strong>growth factor‑mediated pathways and nitric oxide systems.</li> <li>Enhances wound healing, angiogenesis, and tissue repair.</li> </ul> <li><strong>TB‑500 (Thymosin Beta‑4 fragment):</strong></li> <ul> <li>Synthetic peptide representing the active segment of Tβ4.</li> <li>Functions through actin‑binding and cellular organization.</li> <li>Promotes cell migration, angiogenesis, and tissue regeneration.</li> </ul> <li><strong>Synergistic Potential:</strong></li> </ul> <ul> <li style="list-style-type: none;"> <ul> <li>BPC‑157 stabilizes blood vessels and promotes microvascular growth.</li> <li>TB‑500 stimulates endothelial cell migration and actin dynamics.</li> <li>Combined anti‑inflammatory actions may create a favorable environment for tissue repair.</li> </ul> </li> </ul> <p> </p> <p><strong>Research Applications</strong></p> <ul> <li>Tissue regeneration and wound healing studies</li> <li>Angiogenesis and vascular biology research</li> <li>Inflammation modulation and recovery models</li> <li>Musculoskeletal injury and soft‑tissue repair investigations</li> <li>Exploratory therapeutic studies in recovery and rehabilitation</li> </ul> <p class="whitespace-pre-wrap break-words"> </p> <p class="whitespace-pre-wrap break-words"><strong>TB-500 and BPC-157 Research</strong></p> <p>The potential synergistic effects of TB-500 and BPC-157 can be theorized based on their overlapping mechanisms in tissue repair, angiogenesis, and anti-inflammatory responses, as suggested by individual preclinical studies.</p> <p> </p> <p>TB-500 primarily promotes cell migration, angiogenesis, and tissue regeneration by upregulating actin dynamics and modulating inflammation¹. BPC-157, for its part, enhances wound healing, angiogenesis, and tissue repair through its effects on nitric oxide pathways, vascular endothelial growth factor (VEGF), and anti-inflammatory mechanisms².</p> <p> </p> <p>Both peptides share overlapping potential in promoting angiogenesis and reducing inflammation, which could amplify healing processes when combined. TB-500’s ability to stimulate endothelial cell migration may complement BPC-157’s role in stabilizing blood vessels and promoting microvascular growth. Their combined anti-inflammatory actions may also create a more favorable environment for tissue repair.</p> <p> </p> <p>Although direct studies on their combined use are limited, their individual mechanisms suggest a strong theoretical basis for synergistic effects in tissue regeneration and recovery.</p> <p> </p> <p><strong>References</strong></p> <ol> <li> <p>Su, L., Kong, X., Loo, S., Gao, Y., Liu, B., Su, X., Dalan, R., Ma, J., &amp; Ye, L. (2022). Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells. <em>Stem cell research &amp; therapy</em>, <em>13</em>(1), 13.<span> </span><a href="https://doi.org/10.1186/s13287-021-02687-x" rel="noopener" target="_blank">https://doi.org/10.1186/s13287-021-02687-x</a>.</p> </li> <li> <p>Seiwerth, S., Milavic, M., Vukojevic, J., Gojkovic, S., Krezic, I., Vuletic, L. B., Pavlov, K. H., Petrovic, A., Sikiric, S., Vranes, H., Prtoric, A., Zizek, H., Durasin, T., Dobric, I., Staresinic, M., Strbe, S., Knezevic, M., Sola, M., Kokot, A., Sever, M., … Sikiric, P. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. <em>Frontiers in pharmacology</em>, <em>12</em>, 627533.<span> </span><a href="https://doi.org/10.3389/fphar.2021.627533" rel="noopener" target="_blank">https://doi.org/10.3389/fphar.2021.627533</a>.</p> </li> </ol> <p><br><br>Label--<strong>Product Specifications</strong></p> <style type="text/css"> td {border: 1px solid #cccccc;} br {mso-data-placement: same-cell;} .bold {font-weight: bold;} </style> <table> <thead> <tr> <th><strong>Specification</strong></th> <th><strong>BPC-157</strong></th> <th><strong>TB-500</strong></th> </tr> </thead> <tbody> <tr> <td><strong>Sequence</strong></td> <td>Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val</td> <td>Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ)</td> </tr> <tr> <td><strong>Molecular Formula</strong></td> <td>C₆₂H₉₈N₁₆O₂₂</td> <td>C₃₈H₆₈N₁₂O₁₄</td> </tr> <tr> <td><strong>Molecular Weight</strong></td> <td>1419.5 g/mol</td> <td>889.0 g/mol</td> </tr> <tr> <td><strong>PubChem CID</strong></td> <td>9941957</td> <td>62707662</td> </tr> <tr> <td><strong>CAS Number</strong></td> <td>137525-51-0</td> <td>885340-08-9</td> </tr> <tr> <td><strong>Synonyms</strong></td> <td>PL-14736, Body-Protection Compound-157, Bepecin</td> <td>Thymosin-β4 fragment 17-23, TB-500 acetate, Ac-LKKTETQ</td> </tr> </tbody> </table> <p><br>Dosage--<strong>This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.</strong><span> This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.</span><br></p>

--- Image 1 ---
Product Image name: BPTB55-bpc-157-tb-500-blend-10mg-RET.jpg
Product Image URL: https://fmihealth.com/cdn/shop/files/BPTB55-bpc-157-tb-500-blend-10mg-RET.jpg?v=1770933379
Product Image ALT: BPC-157 TB-500 Blend X 10mg
Product Image Size: 2430x2430px

Peptides_Products_FMI, Shop All